The liquid fraction is partitioned into a residua fraction and a light liquid fraction.
Each one of the at least one metal material fraction also includes a respective first operative material fraction and a respective second operative material fraction.
The dried feedstock is screen separated into a coarse fraction and a powder fraction, the coarse fraction including a magnetic fraction and a non-magnetic fraction.
The DYS fraction is then separated form the DYP fraction.
The hydrocarbon fuel may comprise a paraffinic fraction, an olefinic fraction, and an aromatics fraction.
The moiety may also be a targeting moiety, an imaging moiety, a chelating moiety, a charged moiety, or a therapeutic moiety.
Advantageously, the further moiety is a directly or indirectly cytotoxic moiety or a readily detectable moiety.
The traceable surfactant preferably includes a phosphate moiety, a phosphonate moiety, or a phosphinate moiety.
This invention relates to a conjugate of a polymer moiety and an interferon- moiety, an erythropoietin moiety, or a growth hormone moiety
A preferred embodiment of the monosaccharide moiety is a hexose moiety, more preferred is a glucose moiety, and most preferred is a glucose moiety which is bonded to the GalNAc-moiety by an α-1,4 glycosidic bond.
The binding moiety comprises at least one aryl moiety and an acidic moiety which is covalently attached to a phenyl portion of the aryl moiety or to a heteroatom of a heteroaryl portion of the aryl moiety.
The donor moiety and the acceptor moiety exhibit fluorescence resonance energy transfer when the donor moiety is excited and the distance between the donor moiety and the acceptor moiety is small.
The binder portion is, in particular, an antibody portion.
First, the hydrocarbon feed is separated into a C5- cut, a C6-C7 cut, and a C8+ cut.